• Andersen D O, Weber N D, Wood S G. In vitro virucidal activity of selected anthraquinones and anthraquinones derivatives[J]. Antiviral Res, 1991, 16(2): 185-196. doi: 10.1016/0166-3542(91)90024-L

  • Barnard D L, Huffman J H, Morris J L. Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinones derivatives against human cytomegalovirus[J]. Antiviral Res, 1992, 17(): 63-77.

  • Baytop T. 1984. Therapy with Herbs in Turkey. Istanbul: Istanbul Univ. Press, p185-186.

  • Bone K. The herbal treatment of viral infections[J]. Eur J Herbal Med, 1994, 1(): 23-28.

  • Che C T. Plants as a source of potential antiviral agents, Econ[J]. Med Plant Res, 1991, 5(): 167-251.

  • Hayden F G, Belshe R B, Villaneueva C. Management of influenza in households: a prospective randomized comparison of oseltamivir treatment with or without post-exposure prophylaxis[J]. J Infect Dis, 2004, 189(): 440-449. doi: 10.1086/jid.2004.189.issue-3

  • Herekman-Demir T, Öztürk N, Öztürk Y. Hepa-toprotective effect of St[J]. John's Wort. Fund Clin Pharmacol, 2001, 15(): 104-.

  • Hillyard I W. 1980. The preclinical toxicology and safety of ribavirin. In: Ribavirin: A Broad-Spectrum Antiviral Agent (Smith R A, Kirkpatrick W. eds.). New York: Academic Press, p59-71.

  • Hobbs C. St John's Wort. Hypericum perforatum L: a review[J]. Herbal Gram, 1989, 18(): 24-33.

  • Hudson J B, Lopez-Bazzocchi I, Towers G H. Antiviral activities of hypericin[J]. Antiviral Res, 1991, 15(2): 101-112. doi: 10.1016/0166-3542(91)90028-P

  • Hudson J B. Antiviral Compounds from Plants[J]. Florida:CRC Press, 1992, (): p162-.

  • Huffman J H, Sidwell R W, Khare G P. In vitro effect of 1-β-d-ribofuranosy-1, 2, 4-triazole-3-car-boxamide (Virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses[J]. Antimicrob Agents Che-mother, 1973, 3(): 235-241. doi: 10.1128/AAC.3.2.235

  • Khare G P, Sidwell R W, Witkowski J T. Suppression by 1-β-d-ribofuranosyl -1, 2, 4-triazole-3-carboxamide (Virazole, ICN 1229) of influenza virus-induced infections in mice[J]. Antimicrob Agents Che-mother, 1973, 3(): 235-238. doi: 10.1128/AAC.3.2.235

  • Lavie G, Mazur Y, Lavie D. The chemical and biological properties of hypericin compound with broad spectrum of biological activity[J]. Med Res Rev, 1995, 15(2): 111-119. doi: 10.1002/(ISSN)1098-1128

  • Lavie G, Valentine F, Levin B. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin[J]. Proc Natl Acad Sci USA, 1989, 86(): 5963-5967. doi: 10.1073/pnas.86.15.5963

  • Lenard J, Rabson A, Vanderoef R. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: Inhibition of fusion and syncytia formation[J]. Proc Natl Acad Sci USA, 1993, 90(): 158-162. doi: 10.1073/pnas.90.1.158

  • Li H, Jiang H C. Antibacterial effect of the total extract of Hypericum perforatum on clinically isolated bacteria[J]. Guihaia, 2007, 27(3): 466-468.

  • Li K S, Guan Y, Wang J. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia[J]. Nature, 2004, 430(): 209-213. doi: 10.1038/nature02746

  • Liu X J, Li Y L, Xi F Z. The therapeutic function and effection on VEGF, Flt-1 and MVD about photo-activated hypericin to rat C6 glioma[J]. Chin J Lab Diag, 2003, 7(6): 524-526.

  • Nicholson K G, Wood J M, Zambon M. Influenza[J]. Lancet, 2003, 362(9397): 1733-1745. doi: 10.1016/S0140-6736(03)14854-4

  • Nicolaeva V T. Plants used by some nations in the USSR for diseases of the liver and biliary ducts[J]. Rastitel'-nye Resursy, 1977, 13(): 396-403.

  • Öztürk Y, Aydın S, Beis R. Effects of Hy-pericum calycinum L. extract on the central nervous system in mice[J]. Phytotherapy Research, 1996, 10(): 700-702. doi: 10.1002/(ISSN)1099-1573

  • Öztürk Y, Aydın S, Beis R. Effects of Hypericum perforatum L. and Hypericum calycinum L. extracts on the central nervous system in mice[J]. Phytomedi-cine, 1996, 3(): 137-144.

  • Öztürk Y. Testing antidepressant effects of Hy-pericum species on animal models[J]. Pharmacopsy-chiatry, 1997, 30(): 125-128.

  • Öztürk Y, Aydın S, Baser K H C. Hepato-protective activity of Hypericum perforatum L. alcoholic extract in rodent[J]. Phytotherapy Research, 1992, 6(): 44-46. doi: 10.1002/(ISSN)1099-1573

  • Patriarca P A, Weber J A, Parker R A. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic[J]. JAMA, 1985, 253(8): 1136-1139. doi: 10.1001/jama.1985.03350320060017

  • Sandstrom E. Antiviral therapy in human immuno-deficiency virus infection[J]. Drugs, 1989, 38(): 417-450. doi: 10.2165/00003495-198938030-00005

  • Schinazi R F, Chu C K, Babu J R. Anthra-quinones as a new class of antiviral agents against human immunodeficiency virus[J]. Antiviral Res, 1990, 13(5): 265-272. doi: 10.1016/0166-3542(90)90071-E

  • Serkedjieva J, Manolova N, Zgorniak-Nowosielska I. Antiviral activity of the infusion (SHS-174) from flowers of sambucus nigra L., aerial parts of Hypericum perforatum L., and roots of Saponaria officinalis L. against influenza and herpes simplex viruses[J]. Phytother Res, 1990, 4(): 97-100. doi: 10.1002/(ISSN)1099-1573

  • Sidwell R W, Huffman J H, Khare G P. Broad-spectrum antiviral activity of virazole: 1-β-d-ribo-furanosyl-1, 2, 4-triazole-3-carboxamide[J]. Science, 1972, 177(): 705-706. doi: 10.1126/science.177.4050.705

  • Sidwell, R W. 1996. Ribavirin: a review of antiviral efficacy. in: Recent Res Devel, Antimicrob Agents CH (Pandalai G. ed), vol. 1, Kerala, India, Research Signpost, p219-256.

  • Sidwell R W, Huffman J H, Gilbert J. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice[J]. Antimicrob Agents Chemother, 1992, 36(): 473-476. doi: 10.1128/AAC.36.2.473

  • Sidwell R W, Huffman J H, Barnard D L. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor[J]. Antiviral Res, 1998, 37(): 107-120. doi: 10.1016/S0166-3542(97)00065-X

  • Sidwell R W, Smee D F, Huffman J H. Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201[J]. Antiviral Res, 2001b, 51(): 179-187. doi: 10.1016/S0166-3542(01)00149-8

  • Smee D F, Huffman J H, Morrison A C. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities[J]. Antimicrob Agents Chemo-ther, 2000, 45(): 743-748.

  • Tang J, Colacino J M, Larsen S H. Virucidal activity of hypericin against enveloped and non enveloped DNA and RNA viruses[J]. Antiviral Res, 1990, 13(6): 313-325. doi: 10.1016/0166-3542(90)90015-Y

  • Thiers B H. Antiretroviral therapy[J]. J Am Acad Dermatol, 1989, 21/3 I(): 443-454.

  • Jefferson T, Demisheli V. 1998. Socioeconomics of influenza. In: Textbook of Influenza (Nicholson K G, Webster R G, Hay A J. eds. ), Oxford, UK: Blackwell Sciences, p541-547.

  • Vanden Berghe D A, Vlietinck A J, Van Hoof L. Plant products as potential antiviral agents[J]. Bull Inst Pasteur, 1986, 84(): 101-147.

  • Pei-Gen X. 1994. Ethnopharmacological investigation of Chinese medicinal plants. In: Prance, G T, Derek J, March J. (Eds. ), Ethnobotany and the Search for New Drugs, Ciba Foundation Symposium, vol. 185. John Wiley and Sons, Chichester, p169-177.